ctrl K

Tekla Healthcare Investor... (HQH)

NYSE: HQH · Real-Time Price · USD

16.25

0.18 (1.12%)

At close: May 02, 2025, 12:05 PM

Tekla Healthcare Investors Income Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	10.77M	10.29M	8.27M	6.48M	8.93M	7.6M	6.78M	5.62M	4.8M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	10.77M	10.29M	8.27M	6.48M	8.93M	7.6M	6.78M	5.62M	4.8M
Operating Income	-220.27K	-1.19M	-3.67M	-6.23M	-1.97M	-2.87M	-4.12M	-5.16M	-6.28M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	184.95M	56.33M	-194.23M	155.18M	241.2M	-145.29M	69.2M	121.28M	-56.02M
Net Income	184.95M	56.33M	-194.23M	155.18M	241.2M	-145.29M	69.2M	121.28M	-56.02M
Selling & General & Admin	10.99M	11.48M	11.94M	12.71M	10.9M	10.47M	10.9M	10.78M	11.08M
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	10.99M	11.48M	11.94M	12.71M	10.9M	10.47M	10.9M	10.78M	11.08M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	56.39K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	10.99M	11.48M	11.94M	12.71M	10.9M	10.47M	10.9M	10.78M	11.08M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	52.13M	49.44M	47.34M	45.43M	43.87M	42.83M	42.22M	40.65M	39M
Shares Outstanding (Diluted)	52.13M	49.44M	47.34M	45.43M	43.87M	42.83M	42.22M	40.65M	39M
EPS (Basic)	3.55	1.14	-4.1	3.42	5.50	-3.39	1.64	2.98	-1.44
EPS (Diluted)	3.55	1.14	-4.1	3.42	5.50	-3.39	1.64	2.98	-1.44
EBITDA	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
EBIT	-220.27K	-1.19M	-3.67M	-6.23M	-1.97M	-2.87M	-4.12M	-5.16M	-6.28M
Depreciation & Amortization	220.27K	1.19M	3.67M	6.23M	1.97M	2.87M	4.12M	5.16M	6.28M